12:00 AM
 | 
Nov 24, 2003
 |  BioCentury  |  Strategy

Platform acquisitions

Platform acquisitions

Acquirer Date Acquired Value Assets Value chain segment
DuPont Pharma (now part of Bristol-Myers) 1999 CombiChem $95 ...

Read the full 201 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >